• Search
  • Login
  • Register
Menu
  • BJH
  • Home
  • News
    • Newsroom
    • Links
  • CongressUpdate
  • Guidelines
  • Specials
  • Hematotrials
  • Patients
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here

Category

All
  • Alle
  • Healthy Living
  • Pharma News
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
ASH 2023

Interview met dr. Inger Nijhof

subscribe Latest issue All issues Newsletters
Index latest issue
  • Fertility preservation in women before cancer therapy
  • Recent advances in the genomic and epigenomic biology of juvenile myelomonocytic leukaemia
  • BHS guidelines for the treatment of newly diagnosed diffuse large B-cell lymphoma (DLBCL) anno 2020
  • Guidelines of the Belgian Hematological Society for newly diagnosed and relapsed follicular lymphoma anno 2019
  • Rituximab induced serum sickness or immune complex deposition disease: case report and desensitisation protocol
  • Journal Scan
  • New haematology reimbursements in Belgium
ASH 2023

Profylaxe met emicizumab veelbelovend bij jonge kinderen met ernstige hemofilie A zonder FVIII...

ASH 2023

MRD-status nuttig in besluitvorming rond stamceltransplantatie tijdens eerste complete remissi...

ASH 2023

Nieuwe genetische mutatie ontdekt die tot hematologische maligniteit en beenmergfalen leidt

ASH 2023

Bleomycine heeft langdurig nadelige invloed op longfunctie bij Hodgkin-lymfoom

Clinical practice

4:3 Image

Clinical trials

3:2 image

1 2 3 4 5 Next
Top
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2025